SuppliersPortugalMedical equipments, pharmaceuticals and personal care productsMerck Sharp & Dohme, Lda
Merck Sharp & Dohme, Lda
Public recordUnclaimedSME254 public contract awards in 2026 to date across 39 public buyers in Portugal, from BASE.gov records.
NIF 500191360 · CPV 33600000 Pharmaceutical products · CPV 33690000 Various medicinal products · Register edition 15 Aug 2026
The record in one paragraph
Merck Sharp & Dohme, Lda (NIF 500191360) won 254 public contracts worth €152,013,719 from 39 public buyers in Portugal in 2026 to date. Its largest public buyer by value is Instituto Português de Oncologia do Porto Francisco Gentil, EPE, with €19,704,754 across 20 contracts. Most of that value, 100.0% of it, sits in CPV division 33, Medical equipments, pharmaceuticals and personal care products. Source: Portal BASE (base.gov.pt), IMPIC open data, register edition 15 Aug 2026.
Recent awards
Showing 10 of 254Top buyers, 2026
EURWho else wins with these buyers
Questions about Merck Sharp & Dohme, Lda
- How much has Merck Sharp & Dohme, Lda won in Portuguese public tenders in 2026?
- Merck Sharp & Dohme, Lda (NIF 500191360) was awarded €152,013,719 across 254 public contracts published on Portal BASE in 2026 to date, register edition 15 Aug 2026.
- Which public bodies buy from Merck Sharp & Dohme, Lda?
- Merck Sharp & Dohme, Lda won contracts from 39 public buyers in 2026 to date. The largest by value: Instituto Português de Oncologia do Porto Francisco Gentil, EPE (€19,704,754), Unidade Local de Saúde do Algarve, EPE (€18,239,268), Unidade Local de Saúde de Santa Maria, E. P. E. (€14,548,800). Source: Portal BASE, register edition 15 Aug 2026.
- What does Merck Sharp & Dohme, Lda supply?
- The contracts Merck Sharp & Dohme, Lda won in 2026 to date fall under CPV 33, Medical equipments, pharmaceuticals and personal care products, as the buyers classified them with CPV codes on Portal BASE, register edition 15 Aug 2026.
- Who competes with Merck Sharp & Dohme, Lda for the same buyers?
- GlaxoSmithKline-Prod.Farm.Ldª (€56,095,824 awarded, 39 shared buyers), Sanofi - Produtos Farmacêuticos, Lda (€120,001,320 awarded, 38 shared buyers), NOVARTIS FARMA - Produtos Farmacêuticos, SA. (€144,855,836 awarded, 37 shared buyers) won contracts from the same public buyers as Merck Sharp & Dohme, Lda in 2026 to date, under the same CPV divisions, per Portal BASE, register edition 15 Aug 2026.
- When was the most recent public contract of Merck Sharp & Dohme, Lda?
- The most recent contract on record for Merck Sharp & Dohme, Lda is dated 12 Aug 2026, and the first of 2026 is dated 2 Jan 2026, per Portal BASE, register edition 15 Aug 2026.